Literature DB >> 26452524

Rethinking the appraisal and approval of drugs for type 2 diabetes.

Huseyin Naci1, Richard Lehman2, Olivier J Wouters3, Ben Goldacre4, John S Yudkin5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26452524     DOI: 10.1136/bmj.h5260

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Authors:  Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Fürst; Kristina Garuolienė; Martin van der Graaff; Jolanta Gulbinovič; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic-Pekovic; Laura McCullagh; Einar Magnusson; Ellen Nilsen; Gisbert Selke; Catherine Sermet; Steven Simoens; Robert Sauermann; Ad Schuurman; Ricardo Ramos; Vera Vlahovic-Palcevski; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

2.  Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.

Authors:  Andrew McGovern; William Hinton; Ana Correa; Neil Munro; Martin Whyte; Simon de Lusignan
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

3.  Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.

Authors:  Helen J Curtis; John M Dennis; Beverley M Shields; Alex J Walker; Seb Bacon; Andrew T Hattersley; Angus G Jones; Ben Goldacre
Journal:  Diabetes Obes Metab       Date:  2018-06-05       Impact factor: 6.577

4.  Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile.

Authors:  Ana Correa; William Hinton; Andrew McGovern; Jeremy van Vlymen; Ivelina Yonova; Simon Jones; Simon de Lusignan
Journal:  BMJ Open       Date:  2016-04-20       Impact factor: 2.692

5.  Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells.

Authors:  Xuanchun Wang; Samuel M Lockhart; Thomas Rathjen; Hassan Albadawi; Ditte Sørensen; Brian T O'Neill; Nishant Dwivedi; Simone R Preil; Hans Christian Beck; Sally L Dunwoodie; Michael T Watkins; Lars Melholt Rasmussen; Christian Rask-Madsen
Journal:  Diabetes       Date:  2016-08-25       Impact factor: 9.461

6.  Uptake of new antidiabetic medicines in 11 European countries.

Authors:  Nika Mardetko; Urska Nabergoj Makovec; Igor Locatelli; Andrej Janez; Mitja Kos
Journal:  BMC Endocr Disord       Date:  2021-06-25       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.